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Abstract. Twenty-seven tlvpolone de,'ivatives were investigated 
fol' their tumoi*speafic cytotoxicity, using 3 noi7nal hulnan cells 
and 3 human oral tumo,' cell lines. TropolOne derivatives with 
phenolic OH group, hinokithiol, its tosylate and methyl ethe/~: 
have /'elatively highe,' tumor speclficity. 5-Aminoti'opolone 
showed the highest speclficity, whereas 2-alninot/'opone and its 
derivatives showed little o,~ no spectficity. 5-A;ninotropolone 
induced apoptotic cell death characterized by internucleoso;nal 
DNA fragmentation and caspase 3 activation in the human 
promyelocytic leukemic HL-60 cell line. ESR specti'oscopy 
sh,owed that 5-aminotivpolOne produced radical undei' alkaline 
conclition, and efficiently scavenged 02- and NO plvduced by 
HX-XOD reaction and NOC-7, /･espectively. These data suggest 
that 5-aminotropolon,e may induce cytotoxicity by radical-
mediated redox reaction. 
Hinokitiol (compound [1] in Figure 1) and related 
compounds with a tropolone skeleton (1-3), have shown a 
broad spectrum of biological activities, includin.~ antimicrobial 
activity (4), antifungal activity (5), phytogrowth-inhibitory 
activity (6, 7), cytotoxic effect on mammalian tumor cells (8, 9) 
and inhibitory activity on catechol-O-methyltransferase (10) 
and metalloproteases (4). Hinokitiol acetate did not show the 
cytotoxic activity (9), antimicrobial activity or metalloprotease 
inhibition (4), sug.'esting that the biological effects of 
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hinokitiol-related compounds may result from the metal 
chelation between the carbonyl group at C-1 and the hydroxyl 
group at C-2 in the tropolone skeleton. However, a detailed 
study of cytotoxicity induction by tropolone-related 
compounds has not been performed so far. We investigated 
here whether a t tal of 27 compounds, which have a tropolone 
skeleton, display tumo -specific cytotoxic activity, using three 
normal human c lls [gingival fibroblast (HGF), pulp cell 
(HPC), per dontal liga e t fibroblast (HPLF)] and three 
human oral tumor ell lines [submandibular gland carcinoma 
(HSG) nd oral squamous cell carcinoma (HSC-2, HSC-3)] 
a d, and if so, whether they induce apoptosis-associated 
characteristics (such as DNA fragmentation and caspase 
activation) in human tumor cells. We also investigated 
whether a radical-mediated mechanism is involved in the 
tropolone-induced cyiotoxicity, using ESR spectroscopy. 
Materials and Met ods 
Methods. The following chemicals and reagents were obtained from 
the indicated companies: Hinokitiol [1], tropolone [3], tropolone 
tosylate [12] (Tokyo Kasei Kogyo Co., Ltd., Tokyo, Japan); 
Dulbeccos's modified Eagle medium (DMEM), RPMI 1640 (Gibco 
BRL, Grand Island, NY, USA); fetal bovine serum (FBS) (JRH, 
Bioscience, Lenexa. KS, USA); dimethyl sulfoxide (DMSO), 
diethylenetr aminep n aacetic acid (DETAPAC) (Wako Pure 
Chem, Ind, Ltd, Osaka, Japan); 3-(4,5-dimethylthiazol-2-yl)-2,2-
diphenyltetrazolium bromide (MTT), hypoxanthine (HX), xanthine 
oxidase (XOD), 3'-azid0-2', 3'-dideoxythymidine (AZT), 
dideoxycytidine (ddC)(S gma Chem Co., St. Louis. MO, USA); 5,5-
dimethyl-1-pyrro ine-N-oxide (DMPO), superoxide dismutase 
(SOD) from bovine erythrocytes, 1-hydroxyl-2-0x0-3-N-3-methyl-
3-aminopropyl)-3-methyl-1-triazene (NOC-7) and 2-(4-
arboxyphenyl)-4 4,5,5-tetramethylimidazoline-1-0xyl-3-0xide 
(carboxy-PTIO) (Dojin, Kumamoto, Japan). 
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Figure I . 
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Synthesis of tropolones. Tropolones were synthesized, according to the 
published reports: Hinokitiol (P-thujaplicin) [1] (11, 12), Y-thujaplicin 
[2] (12-14), tropolone [3] (15, 16), 5-bromotropolone [4] (17), 5-
nitrotropolone [5] (18), 5-aminotropolone [6] (19, 20), 5-
nitrosotropolone [7] (21, 22), 5-cyanotropolone [8] (23), 3-
bromotropolone [9] (24, 25), hinokitiol mixture [10] (12, 14), Y-
thujaplicin tosylate [1l] (26), tropolone tosylate [12] (27), 5-
bromotropolone tosylate [13] (28), hinokitiol tosylate mixture [14] 
(26), hinokitiol methyl ether mixture [15] (29), Y-thujaplicin methyl 
ether [16] (29), 2-methoxytropone [17] (30), 2-bromo-7-
methoxytropone [18] (25), 3-brom0-2-methoxytropone [19] (25), 5-
brom0-2-methoxytropone [20] (30), 2,4-dibrom0-7-methoxytropone 
[2l] (30), 2,4,6-tribrom0-7-methoxytropone [22] (30), 2-
chlorotropone [23] (31), 2,7-dibromotropone [24] (31), 2-
aminotropone [25] (16, 32), N-acetyl-2-aminotropone [26] (16), N-
methyl-2-aminotropone [27] (16). 
Cell culture. Three human oral tumor cell lines (HSG, HSC-2, HSC-3) 
and three human normal cells [HGF (5-8 population doubling level 
(PDL)), HPC (5-8PDL), HPLF (5-8PDL)] were cultured in DMEM 
supplemented with 10% heat-inactivated FBS. Human promyelocytic 
lenkemic Hlj60 cells were cultured in RPMI 1640 supplemented with 
10% FBS. Normal cells were prepared from periodontal tissues, 
according to the guidelines of Meikai University Ethics Committee, 
after obtaining informed consent from the patients. 
Assay for cytotoxic activity. Cells (other than HL-60 cells) were 
inoculated at 12 x 103 cells/well in 96-microwell (Becton Dickinson 
Labware, NJ, USA), unless otherwise stated. After 24 hours, the 
medium was removed by suction with an aspirator and replaced 
with 0.1 mL of fresh medium containing various concentrations of 
test compounds. Cells were incubated for another 24 hours and 
the relative viable cell number was then determined by MTT 
method. In brief, cells were replaced with fresh culture medium 
containing 0.2 mg/mL MTT and incubated for another 4 hours. 
The cells w re lyse  wi h 0.1 mL of DMSO, and the absorbance 
at 540 nm of the cell lysate was determined, using a microplate 
reade  (Biochromatic Labsystem, Helsinki, Finland) (33). A540 of 
control cells were usually in the range of 0.40 to 0.90. The 50% 
cytot xic conc ntration (CC50) was determined from the dose-
response curve. Tumor specificity (TS) was determined by the 
fol wing equ ion. 
[CC50 (HGF)] + [CC50 (HPC)] + [CC50 (HPLF)] 
TS =
[CC50 (HSG)] + [CC50 (HSC-2)] + [CC50 (HSC-3)] 
The viability of HL-60 cells was determined by trypan blue 
exclusion cell. HL-60 cells were inoculated at 5 x 104/0.1 mL in 96-
microwell and various concentrations of test compounds were 
added. After incubation for 24 hours, the viable cell number was 
determined as described previously. The cell density of control cells 
at cell harvest was in the range of 8-9 x 105/mL. 
Assay for DNA fragm ntation. Cells were lysed with 50 uL Iysate 
buffer [50 M Tris-HCI (pH 7.8), 10 mM EDTA, 0.5% (w/v) 
sodium N-lauroyl-sarcosinate solution] . The solution was incubated 
with 0.4 mg/mL RNase A and 0.8 mg/mL proteinase K for 1-2 
hours at 50' C. After incubation, the lysate was mixed with 50 uL of 
Nal solution [7.6 M Nal, 20 mM EDTA-2Na, 40 mM Tris-HC1, pH 
8.0]. Two hundred and fifty uL of ethanol was added and 
centrifuged for 20 minutes at 20,000 xg. The precipitate was washed 
with I mL of 70% ethanol a d dissolved in TE buffer (10 mM Tris-
HC1, I mM EDTA, pH 7.5). A sample (10-20 uL) was applied to 
2% garose gel electrophoresis in TBE buffer (89 mM Tris-HC1, 
89 mM boric acid, 2 mM EDTA, pH 8.0). DNA molecular marker 
(Takara) and DNA fr m apoptotic HL-60 cells induced by UV 
irradiation wer  used for calibration (34). The DNA fragmentation 
pattern wa  examined n photographs taken under UV 
illuminati n. 
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Table I. Cytotoxic activity of tropolones. 
Cytotoxic activity (CC50: mM)
Molecular 
Compd. Weight 
Normai human cells Human tumor cell lines 
HGF HPC HPLF HS G HSC-2 HSC-3 TS 
?
?
?
?
?
?
?
?
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
164.20 
164.20 
122.12 
201.02 
167.12 
137.14 
151.12 
147.13 
201.02 
164.20 
318.3_ 9 
276.31 
355.21 
318.39 
178.23 
178.23 
136.15 
215.05 
215.05 
215.05 
293.94 
372.84 
140.57 
263.92 
121.14 
163.17 
135.16 
1.93 
1.79 
2.10 
1.40 
2.05 
O.63 
O.13 
>2.72 
1.91 
1.86 
O.11 
0.076 
O.0084 
O.14 
1.64 
>2.24 
>2.94 
> 1.86 
O.11 
> I .86 
O.22 
O.027 
O.23 
O.0076 
3.12 
>2.45 
0.62 
1.72 
1.55 
1.12 
1.37 
1.52 
1.04 
O.066 
>2.72 
1.60 
1.63 
O.17 
O.069 
O.014 
O.10 
1.58 
2.11 
>2.94 
1.76 
0.16 
> I .86 
O.34 
O.075 
O.18 
O.049 
2.91 
>2.45 
1 .27 
1.73 
1.55 
1.23 
1 .49 
2 . 27 
O . 85 
O.12 
>2.72 
1.59 
1.36 
O.12 
O.033 
0.014 
O.094 
1.48 
1.68 
> 2.94 
> 1.86 
O.14 
> I .86 
O.16 
O.048 
O.085 
>0.034 
2.97 
>2.45 
2.23 
1.52 
1 .22 
O.81 
O.96 
1.93 
O.14 
O.02 
>2.72 
1.30 
1 .29 
O.022 
0.025 
O.0056 
0.019 
O.84 
i.O1 
2.24 
1.30 
0.074 
2.20 
O.OI 1 
O.013 
O.05 
O.045 
2.94 
2.26 
O.34 
O.17 
O.13 
O.14 
O.39 
O.53 
O.058 
0.046 
O.082 
O.17 
O.10 
O.041 
O.022 
O.014 
O.031 
O.51 
1.39 
2.59 
O.38 
O.074 
1.71 
O.27 
0.008 
O.19 
O.027 
2.42 
>2.45 
1.40 
0.17 
O.13 
O.14 
O.39 
0.53 
O.058 
O.16 
O.082 
0.17 
O.10 
0.041 
O.022 
O.014 
O.031 
O.51 
1.39 
2.59 
O.38 
O.084 
1.71 
O.27 
O.O11 
O.19 
O.015 
2.42 
>2.45 
1 .40 
2,9 
3*3 
4,1 
2.5 
2.0 
9*9 
1.4 
> <2.8 
3.1 
3,4 
3,8 
2,6 
1.1 
4.1 
2.5 
> 1,6 
> 1.2 
>2.7 
1.8 
> 1.0 
> 1.3 
4.7 
1.1 
1.0 
1.2 
> < 1.0 
1.3 
Assay for caspase activation. Cells were washed with PBS and 
lysed in lysis solution (MBL, Nagoya, Japan). After standing for 
10 minutes on ice and centrifugation for 5 minutes at 10,000 x*', 
the supernatant was collected. The lysate (50 uL, equivalent to 
200 ug protein) was mixed with 50uL 2x reaction buffer (MBL) 
containing substrates for caspase 3 (DEVD-pNA (p-
nitroanilide)), caspase 8 (IETD-pNA) or caspase 9 (LEHD-
pNA). After incubation for 3 hours at 37'C, the absorbance at 
405 nm of the liberated chromophore pNA was measured by 
plate reader. 
Assay for radical intensity. The radical intensity of the test sample 
was determined at 25'C in 0.1 M Tris-HCI buffer (pH 7.4), 0.1 M 
NaHC031Na2C03 buffer (pH 9, 10) or in 0.1 M KOH (pH 12.5), 
using ESR spectroscopy (JEOL JES REIX, X-band, 100 kHZ 
modulation frequency). Instrument settin*"s: center field, 336.0:t5.0 
mT; microwave power, 8 mW; modulation amplitude, 0.1 mT; gain, 
630; time constant, 0.03 seconds; scannin*' time, 2 minutes. The 
radical intensity was defined as the ratio of peak height of these 
radicals to that of MnO (35). 
To determine 02-, produced by HX-XOD reaction (total 
volume: 200 uL) [2 mM HX in 0.1 M phosphate buffer (pH 7.4) 
(PB) 50uL, O.5 mM DETAPAC 20 uL, 8 % DMPO 30 uL, 
sample (in DMSO) 40 uL, H20 or SOD 30 uL, XOD (0.5 U/mL 
in PB) 30 uL], the gain, time constant and scanning time were 
chang d to 500, 0.1 seconds and I minute, respectively. The 
r dic l intensity ¥v s determined I minute after mixing. The 02-
scavenging activity ¥vas expressed as SOD unit/mg sample, by 
calibration with th  s andard curve of SOD (9). The 
concent ation required to reduce the radical intensity of 
DMPO-OOH by 50% (IC50) was determined from the dose-
response curve. 
For the determination of NO radical, sample was added to the 
reaction mixture of 20 uL C-PTIO and 50 uL NOC-7 in 0.06 M 
phosphate buffer, pH 7.4. The gain and scanning time were 
changed to 250 and 2 minutes, respectively. The NO radical 
intensity ¥vas defined as the ratio of peak height of the Ist peak of 
carboxy-PTI, which was produced by the reaction of NO (derived 
from NOC-7) and carboxy-PTIO to that of MnO (35). 
Assay for anti-hulnan imlnu,nodeficiency virus (HIV) activity. MT-4 
cells ¥vere infected with HIV-ImB at a multiplicity of infection 
(m.o. .) of 0.01. HIV- or mock- infected (control) MT-4 cells (1.5 x 
10)/mL, 200uL/well) were placed into 96-well microtiter plates and 
incubated in the presence of various concentrations of test samples. 
After incubation for 5 days at 37'C in a 5% C02 mcubator, cell 
viability was quantified by a colorimetric assay (at 540 nm and 690 
nm), monitoring the ability of viable cells to reduce MTT to a blue 
formazan product. The CC50 and 50% effective concentration 
(EC50) were determined from the dose-response curve with mock-
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Table II. Anti-HIV activity of tropolones. 
Compd. CC50 (mM) EC50 (mM) SI 
?
?
?
?
?
?
?
?
?
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
AZT 
ddC 
0.00783 
0.00156 
0.0103 
0.0200 
O.136 
0.0363 
O.OOI02 
0.204 
0.0224 
0.00273 
0.0441 
O.0266 
0.00583 
0.00946 
0.594 
0.336 
O.551 
0.272 
0.0115 
O.483 
0.0638 
0.00156 
0.0301 
0.00268 
0.807 
0.722 
O.551 
0.213 
>5.000 
>0.00974 
>0.00195 
>0.0131 
> 0.0398 
>0.239 
> 0.0583 
>0.00212 
>0.272 
>0.0398 
> O .00974 
>0.126 
>0.0290 
> O.0225 
> 0.025 1 
>1.12 
>1.12 
> I .47 
>0.930 
> 0.0372 
>0.930 
>0.136 
> O. 00429 
>0.0569 
>0.00606 
> 1.65 
> I .23 
> I .27 
O.OO0021 
0.00309 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
<1 
9973 
> 1616 
infected or HIV-infected cells, respectively (36). All data represent 
the mean values of triplicate measurements. The anti-HIV activity 
was evaluated by selectivity index (SI), which was calculated by the 
following equation: 
SI=CC50/EC50 
Results 
Structure and activity relationship. We first investigated 27 
tropolones for their relative cytotoxicity against three human 
normal cells (HGF, HPC, HPLF) and three human oral 
tumor cell lines (HSG, HSC-2, HSC-3) (Table I). Tropolone 
[3] showed higher cyiotoxicity against tumor cell lines [CC50 
(HSG) = 0.81 mM; CC50 (HSC-2) = 0.14 mM; CC50 (HSC-
3) = 0.14 mM] than against normal cells [CC50 (HGF) = 2.10 
mM; CC50 (HPC) = 1.12 mM; CC50 (HPLF) = 1.23 mM], 
yielding the tumor-specific cytotoxicity index (TS) of 4.1. In 
general, tropolone [3] and its derivatives with phenolic OH 
group [1=2, 4-10] showed relatively higher TS values. Among 
them, 5-aminotropolone [6] showed the highest tumor 
specificity (TS=9.9). However, 2-aminotropone [25j and its 
derivatives [26, 27] showed little or no tumor specificity 
[TS=1.0-1.3]. Hinokithiol Ll] and its tosylate L11, 14] and 
methyl ethers L15, 1~] showed slightly lower tumor specificity 
(TS=2.9, 3.8, 4.1, 2.5, 1.6) than tropolone [31 . Compounds L7, 
13, 19, 23, 24] were highly cytotoxic, but showed essentially 
no tumor specificity (TS=1.4, 1.1, 1.8, 1.1, 1.0). 
A11 compounds showed no anti-HIV activity (selectivity 
index (SI) > 1), whereas two positive controls, such as AZT 
and ddC, showed potent anti-HIV activity (SI=5617 and 
2002, respectively) (Table II). 
Apoptosis induction. 5-Anrinotropolone L~] induced 
internucleosomal DNA fragnlentation, a biochemical hallmark, 
in HL-60 cells (Figure 2). The optimal concentration was 
0.029-0.058 mM and higher concentration (0.117 mM) was 
much less active. 5-Aminotropolone [6j activated the caspase 
3 to a comparable extent as that attained by actinomycin D, 
without affecting caspase 8 and 9 activity (Figure 3). 
Radicalgeneration. 5-Aminotropolone 161 produced radical 
under alkaline condition. At an optimal condition (pH 9.0), 
multiple peaks of radical were produced (Figure 4). 5-
Aminotropolone [6] efficiently scavenged 02- (generated 
by HX-XOD reaction) (IC50=0.029 mM) (Figure 5) and 
NO (generated from NOC-7) (IC50=0.017 mM) (Figure 6). 
Discussion 
We found that tropolone [3] showed higher cyiotoxic activity 
and tumor-specific cytotoxicity (TS=4.1) than hinokitiol [1] 
(TS=2.9). Since 2-methoxytropone 117] showed much 
reduced cyiotoxicity compared to tropolone, metal chelation 
between the carbonyl group at C-1 and the hydroxyl group at 
C-2 might be responsible for the cyiotoxicity induction, as has 
been reported in hinokitiol-related compounds (4, 9). It was 
unexpected that 2-chlorotropone 123] , which has replaced the 
hydroxyl group at C-2 by C1, showed comparable cytotoxicity 
against both normal and tumor cells, yielding essentially no 
tumor specificity (TS = 1.1). 
The present study demonstrated, for the first time, that 
introduction of the amino group at C-5 in tropolone [6] 
significantly enhanced the tumor-specific cytotoxicity 
(TS=9.9), and t at this compound induced apoptotic cell 
death ch racterized by caspase 3 activation and DNA 
fragmentation. At present, the mechanism by which 5-
aminotropolone 16] activated caspase 3 is unclear, since this 
compound did not significantly activate caspase 8 
(mitochondria-independent extrinsic pathway) and caspase 
9 (m ochondria-dependent intrinsic pathway) (37). 
We found tha  5-aminotropolone [6] was more cytotoxic, 
produced higher amounts of radical and scavenged 02- and 
NO radicals more efficiently than azulenes (38). This suggests 
th t 5-aminotropolone [6] may induce cyiotoxicity by radical-
mediated redox r action. Higher dipole moment of 5-
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Figure 4' ESR s!'e rnl of 5-anlino"rJPolane [61 rl 'ngl'7iL) at increasingl)H' 
amlnotropolone [6] may produce higher SI value Since 2-
aminotropolone [25] had a much lower Sl value, the effect 
of the fu:nctional group may be smBi] Further studies are 
underway ta test this possibllity 
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